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Objective. Substantial investment in electronic health records (EHRs) has provided
an unprecedented opportunity to use clinical decision support (CDS) to increase guide-
line adherence. To inform efforts to maximize adoption, we characterized the adoption
of an otitis media (OM) CDS system, the impact of performance feedback on adoption,
and the effects of adoption on guideline adherence.
Study Setting. A total of 41,391 OM visits with 108 clinicians at 16 pediatric practices
between February 2009 and August 2010.
Study Design. Prospective cohort study of EHR-based CDS adoption during OM
visits, comparing clinicians receiving performance feedback to none. CDS was avail-
able to all physicians; use was voluntary.
Data Collection. Extraction from a common EHR.
Principal Findings. Clinicians and practices used the CDS system for a mean of 21
percent (range: 0–85 percent) and 17 percent (0–51 percent) of eligible OM visits,
respectively. Clinicians who received performance feedback reports summarizing
CDS use and guideline adherence had a relative increase in CDS use of 9.0 percentage
points compared to others (p = .001). CDS adoption was associated with increased
OM guideline adherence. Effects were greatest among clinicians with the lowest adher-
ence prior to the study.
Conclusions. Performance feedback increased CDS adoption, but additional strate-
gies are needed to integrate CDS into primary care workflows.
Key Words. Decision support, feedback, electronic medical record, otitis media,
quality of care
The investment of $19 billion to promote the adoption of electronic health
records (EHRs) by the American Recovery and Reinvestment Act (ARRA) of
2009 has provided an unprecedented opportunity to improve health care





quality through health information technology (HIT) (American Recovery
and Reinvestment Act 2009; Blumenthal 2009). Within ARRA, the Health
Information Technology for Economic and Clinical Health Act (HITECH)
authorizes incentive payments through Medicare and Medicaid to individual
clinicians and health systems when they use EHRs to improve the delivery of
care. These “meaningful use” incentives are substantial, with up to $44,000
available to individual providers through Medicare and $63,750 through
Medicaid (Centers for Medicare and Medicaid Services 2010). This support
has accelerated EHR adoption with over 50 percent of practices and 80 per-
cent of health systems now using EHRs, up by more than 33 and 71 percent
since 2008, respectively (U.S. Department of Health and Human Services
2013).
Among the best studied tools to improve care through EHRs, clinical
decision support (CDS) systems provide intelligently filtered, appropriately
timed, and actionable information to clinicians at the point of care (Osheroff
et al. 2005; Shojania et al. 2009). Once deployed, CDS has resulted in
improvements to health care processes, including medication prescribing,
vaccination, and the ordering of medical tests (Osheroff et al. 2005; Shojania
et al. 2009; Bright et al. 2012), and there is additional evidence that CDS may
result in improved outcomes and reduced treatment costs (Bright et al. 2012).
Overall, CDS has proven most effective when it provides recommendations
within the context of workflows, when alerts appear without delay in an easily
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accessible location, and when the system requires clinicians to enter minimal
or no additional information (Bates et al. 2003; Garg et al. 2005; Kawamoto
et al. 2005).
Despite these well-established rules, the magnitude of the benefit of
CDS has been modest. A recent systematic review of the impact of CDS at the
point of care found a median improvement of 4.2 percent in health care pro-
cess adherence and 3.8 percent for vaccination and test ordering (Shojania
et al. 2009). Studies have shown that as many as 49–96 percent of alerts are
overridden or ignored by physicians in a variety of care settings (Weingart
et al. 2003; Hsieh et al. 2004; van der Sijs et al. 2006; Lin et al. 2008). Exces-
sive numbers of alerts often result in alert fatigue (Ash et al. 2007), declining
clinician responsiveness to a particular type of alert after repeated exposure
over a period of time (Embi and Leonard 2012), which might diminish the
effectiveness of CDS systems and potentially result in serious consequences
for patients (Carspecken et al. 2013).
Physician performance feedback represents a promising strategy to
increase the salience of CDS, minimize alert fatigue, and maximize the ben-
efits of CDS for quality. Feedback addresses the well-described inability of
physicians to accurately evaluate their own performance (Davis et al. 2006).
Previous studies have shown that feedback is most effective when rates of
adherence to practice guidelines are low ( Jamtvedt et al. 2006a,b), when
the information is directly useful for care (Kanouse and Jacoby 1988), and
when practitioners are motivated to change (Mugford, Banfield, and
O’Hanlon 1991). In particular, feedback that defines “achievable bench-
marks” (Kiefe et al. 1998; Weissman et al. 1999) has been found to improve
outcomes (Kiefe et al. 2001). While these results are promising, the impact
of feedback on clinician use of CDS systems has not been well studied.
To address this gap in the literature, we studied the impact of feedback
in improving CDS adoption as part of a larger trial of the effectiveness of
CDS for otitis media (OM) (Forrest et al. 2013). OM is the third most com-
mon reason for pediatric office visits (Forrest et al. 1999), the leading cause
of subspecialist referrals (Froom et al. 1990), and the most common reason
for antibiotic prescribing in the United States. OM care is characterized by
practice variability, resulting in the overuse of antibiotics (Lyon et al. 1998)
and antibiotic resistance (Dagan et al. 2000). By 1 year of age, 60 percent
of all children have experienced at least one episode and 17 percent have
had three or more (Leibovitz 2003). Ninety percent of all children will have
an episode of OM by school entry (Tos 1984). Indicative of the burden of
OM, the annual national costs of acute otitis media (AOM) and otitis media
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with effusion (OME) are $3.0 and $4.0 billion, respectively (Marcy et al.
2001; Shekelle et al. 2003). To improve outcomes for children with AOM
and OME, organizations including the American Academy of Pediatrics
(AAP), the American Academy of Family Physicians (AAFP), and the
Agency for Healthcare Research and Quality (AHRQ) have developed and
promulgated guidelines for OM (American Academy of Family Physicians
2004; American Academy of Pediatrics 2004; Shekelle et al. 2010). How-
ever, prior studies have documented poor adherence to these guidelines
(Garbutt, Jeffe, and Shackelford 2003; Vernacchio, Vezina, and Mitchell
2006, 2007).
In an effort to improve adherence, we developed a multifaceted CDS to
promote adherence to guideline-based recommendations individualized to
the patient’s history and presentation (Forrest et al. 2013). Using a factorial
design, we randomized practices to receive CDS and/or clinician perfor-
mance feedback. In the trial, both CDS and performance feedback proved
effective for improving adherence to otitis media guidelines. The present
study extends our prior work by focusing exclusively on clinicians who had
access to the CDS tool in the larger trial. Specifically, we conducted this study
to characterize patterns of adoption of the CDS system (aim 1), assess the
impact of performance feedback on CDS adoption by primary care clinicians
(aim 2), and measure the impact of CDS use on guideline adherence (aim 3).
We hypothesized that performance feedback would increase CDS adoption.
Conceptual Framework
Rogers’ Theory of the Diffusion of Innovation guided the software devel-
opment process and our analysis of system use (Rogers 2003). Adoption
refers to the decision to make full use of an innovation. Rogers’ Theory
argues that an innovation will be more widely adopted if it (1) confers a
relative advantage compared to existing approaches, (2) is compatible with
existing values, experiences, and needs of adopters, (3) has limited com-
plexity vis-a-vis other technologies in use, (4) can be tried on a limited
basis, and (5) has observable benefits. In the case of the OM CDS, the
system was designed to bring OM guidelines to clinicians with minimal
effort, appear exclusively at visits by children with ear problems, gather
only the few data elements needed to produce specific recommendations
(Bates et al. 2003), and allow for the system to be easily tried by any clini-
cian. Conceptually, feedback in the form of individual performance sum-
maries and comparisons of each clinician to others in his or her practice
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and the broader clinical network was designed to allow clinicians to read-
ily observe benefits of system use.
MATERIALS ANDMETHODS
Data Sources
A single EHR system (EpicCare, Epic Sytems, Inc, Verona, WI, USA), used
for documenting OM care at all study practices, served as the primary data
source. We extracted data on decision support use from the web service exter-
nal to the EHR that delivered the OMCDS in this study (Fiks et al. 2012). We
then validated metrics on adherence to practice guidelines and other data
elements with iterative rounds of review of up to 100 charts by primary care
pediatricians on the research team.
Study Design, Setting, and Participants
This manuscript reports a secondary analysis of data prospectively collected
between February 2009 and August 2010 as part of a cluster randomized trial
of OM CDS (Forrest et al. 2013). In brief, we invited all 27 practices within a
multistate, academic medical center-owned, primary care practice-based
research network caring for more than 200,000 children and adolescents. Fol-
lowing a web-based presentation of the study, 24 practices agreed to partici-
pate in the initial trial. From this group, the 16 practices randomized to receive
decision support were further randomized at the practice level to physician
performance feedback (eight practices) or none. Three of these practices were
urban, resident teaching practices, with a >5-year history of CDS use and a
long-standing program of teaching evidence-based care. Figure 1 outlines
how we derived the study sample of 41,391 visits at 16 practices with 108 clini-
cians. Study participants included all nontrainee pediatric clinicians at
involved sites (physicians and nurse practitioners). To focus on clinicians regu-
larly treating OM, we excluded those with fewer than 25 otitis visits during
the 21-month study period. Consistent with national guidelines for the man-
agement of OM at the time of the study, all visits by children from 2 months
through 12 years of age with a diagnosis of AOM or OME were included in
the analysis (American Academy of Family Physicians 2004; American Acad-
emy of Pediatrics 2004). Members of the research team visited all study sites
to explain the study, reviewOM guidelines, and instruct practitioners on deci-
sion support use.
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Figure 1: Study Sample
Notes. The period prior to CDS implementation includes the 14 months prior to the baseline per-
iod in this study. The baseline period includes the 12 months after the CDS was implemented.
The feedback period includes the 10 months in which half of the practices received CDS only and
half received CDS plus clinician performance feedback.
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Clinical Decision Support System
Following widely used standards and with input from a local advisory panel
that provided advice to adapt national guidelines for local use, we designed,
prototyped, pilot tested the system with clinicians, and then implemented the
study’s CDS system. However, no formal usability testing was conducted.
The OM clinical decision support intervention consisted of three primary
components (Figure S1). Two components appeared for any visit with an ear-
related problem or for any child with a recent OM history. The first compo-
nent (“history panel”) provided an aggregated history of previous otitis media
encounters, including office visits, telephone encounters, audiograms, subspe-
cialist referrals, and surgery. A child’s past antibiotic history was also summa-
rized. The second component (“documentation panel”) included a data-
gathering tool for recording, according to national guidelines, the OM-related
history of present illness and findings from the physical exam. The final com-
ponent (“order entry panel”) was launched by clinicians and, informed by the
history and documentation panels, displayed guideline-based recommenda-
tions for treatment, including indicated antibiotics, diagnosis, referral, analge-
sic use, and a link to a clinically appropriate order set. In addition, the tool
provided patient-specific discharge instructions. Through the order entry
panel, clinicians could also choose to have the CDS write the history of the
present illness, ear exam, assessment and plan, or patient instructions relevant
to an OM encounter, reducing the burden of data entry for clinicians. The
CDS was programmed using a web service that was not part of the EHR but
appeared as part of the visit navigator and gathered data from and returned
information through the EHR (Fiks et al. 2012).
Physician Performance Feedback
After an initial 12-month period of CDS use alone (baseline), six rounds of
feedback were hand-delivered over 10 months (period 2) to the practice man-
ager of sites randomized to feedback who then distributed the reports to prac-
ticing clinicians. Nonfeedback practices had access to the CDS, but there was
no ongoing interaction with the study team in lieu of feedback. We added met-
rics of guideline adherence for OM to the reports in a step-wise fashion. Ulti-
mately, the reports included a measure of overall CDS use based on use of the
CDS “documentation” or “order entry” panels, the first measure added, as
well as four measures of adherence to AAPAOM guidelines (American Acad-
emy of Pediatrics 2004). For AOM, they included (1) appropriate use of
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amoxicillin as a first-line antibiotic, (2) use of high-dose amoxicillin, (3) pain
assessment, and (4) use of analgesia. For each of the metrics as well as overall
tool use, the reports included the performance of the clinician, his or her prac-
tice, and the network as a whole (Figure S2). Data on the top 10 percent of per-
formers throughout the care network were also included.
Outcome Measures
Aim 1 of this study characterized the adoption of the CDS. The primary out-
come of aim 2, the study of the impact of feedback on adoption, was any use of
the “documentation” or “order entry” panels as described above. This out-
come included clinician use of the CDS to document any aspect of the history,
physical, assessment and plan, or patient instructions, as well as using the tool
to place any order, for example, an antibiotic prescription, using the tool. We
were unable to assess how the history panel was used as it was passively visible
at all otitis visits and did not require clinician interaction.
Outcomes for aim 3 focused on adherence to OM guidelines and were
based on adherence to guideline recommendations for OM pain manage-
ment, diagnostic documentation, and medication management as adapted
from national guidelines. The pain treatment metric was satisfied by the pre-
scription of an analgesic, the recommendation of an analgesic in patient
instructions handed to families on discharge, or both. All metrics were consid-
ered except avoidance of antihistamines and decongestants, which was
achieved at nearly all visits. In addition, we created a comprehensive measure
separately for AOM andOME guideline-adherent care. This measure was sat-
isfied when all applicable guideline adherence metrics at an eligible visit, one
at which at least three metrics applied, were achieved.
Covariates
For all visit-level analyses, covariates included factors potentially influencing
the association of CDS use and the outcomes of tool use and guideline
adherence at the visit level. Patient characteristics included gender, age, and
presence of a comorbidity that increases the risk of OM based on national
guidelines (American Academy of Family Physicians 2004; American Acad-
emy of Pediatrics 2004). Visit characteristics included the visit type (sick or
well), when the visit was for AOM or OME, and the number of diagnoses as a
proxy for visit complexity. Clinician characteristics included gender, years in
practice (<5, 5–15, >15), the proportion of visits by children <3 years old seen
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by a clinician, the proportion of OM visits by children with a high-risk comor-
bidity, the proportion of children with ≥3 diagnoses at an OM visit, and the
burden of OM (defined as the average number of otitis media visits per clini-
cians per clinical day). The clinician characteristics described above were the
only covariates in the clinician-level analyses for aim 2.
Statistical Analyses
For aim 1, we estimated the proportion of all visits at which the tool was used
at both the physician and practice level. Using a marginal model with an inde-
pendence correlation structure, and a logit link and accounting for clustering
at the practice level with robust standard error estimates, we then examined
the association between physician, child, and visit characteristics and CDS
tool use.
For aim 2, we then modeled the association of feedback with CDS adop-
tion by examining the interaction of the feedback intervention with time. We
examined this association at two levels: (1) a visit-level analysis that examined
overall patterns and (2) a clinician-month analysis that recognized adoption as
a clinician-level process and considered whether clinicians used the tool at all
in any given month. Both analyses used marginal models with logit links, clus-
tered by practice. We then compared the importance of feedback as a determi-
nant of tool use for clinicians with low versus high adherence to OM
guidelines prior to the study start.
For aim 3, we examined the association of tool use and guideline adher-
ence among the entire study sample of clinicians, all of whom had access to
the CDS. First, we again used marginal models as described previously to esti-
mate the association between tool use and the achievement (yes/no) of com-
prehensive guideline-based care as well as each individual metric. Using
similar models, we then explored the association between tool use and guide-
line adherence separately for physicians with low, intermediate, or high per-
formance for eachmetric prior to CDS implementation.
To contextualize our findings, we gathered qualitative comments regard-
ing the system through informal conversations at each study site each time
feedback was delivered and organized the comments according to Rogers’
Theory (Rogers 2003).
Our Institutional Review Board approved the study and practices
consented to participate. We used R version 2.14.1 (Vienna, Austria) and Stata
version 12.1 (College Station, TX, USA) for all analyses.
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RESULTS
Study Visits and Population
Table 1 describes the study visits, clinicians, and children. Most OM care was
delivered at acute care visits and nearly half of OM visits had a single diagno-
sis. The two study groups (Feedback and CDS vs. CDS-only) differed in sev-
eral characteristics. The CDS-only group was slightly more likely to deliver
OM care at sick visits, record a diagnosis of AOM, and list a single diagnosis
for the encounter. The CDS-only group also had a lower proportion of visits
from patients with three or more diagnoses and was less likely to deliver OM
care to children >5 years of age.
Adoption
Overall adoption of the OM CDS tool was low, and we found a high level of
variability in tool use at the clinician and practice levels. Two clinicians (1.9
percent) in the sample never used the OM tool, and 12 (11.1 percent) used the
tool during a 3-month trial period in which the intervention was tested but did
not use the CDS during the study period. Forty-two (38.9 percent) of the 108
clinicians in the sample used it at less than or equal to 10 percent of visits, 22
(20.3 percent) clinicians at 10–25 percent of visits, and 30 (27.7 percent) at
greater than 25 percent of visits. Overall, clinicians used the OM CDS at a
mean of 21.3 percent of eligible OM visits (standard deviation 26 percent;
median 8.8 percent, range: 0–84.8 percent).
At the practice level, the CDS tool was used at a mean of 16.8 percent of
visits (standard deviation 13 percent; median 15.1 percent, range: 0.0–51.1
percent). All urban teaching practices in the network were above the median
rate of use, and this group included the site with highest level of use.
In multivariable models standardized for characteristics of visits, clini-
cians, and patients, tool use was significantly more frequent at sick visits than
well (17 percent vs. 8 percent), at visits with an AOM diagnosis compared to
OME (18 percent vs. 13 percent), and at visits with fewer diagnoses (21 percent
at visits with 0–1 diagnosis vs. 9 percent at visits with ≥6) (p < .01 for all). Tool
use was more common among clinicians with a lower OM practice burden
who care for fewer children with OM (25 percent vs. 14 percent), and when
the patient was between 24 and 60 months compared to ≤6 months (18 per-
cent vs. 14 percent), an age group at higher risk of adverse outcomes (p = .05
and .02, respectively).
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Table 1: Visit, Clinician, and Patient Characteristics across Sixteen Practices








(n = 41,391), % (n = 22,256), % (n = 19,135), %
Visit characteristics
Visit type
Sick 38,585 (93.2) 20,670 (92.9) 17,915 (93.6)
Well 2,806 (6.8) 1,586 (7.1) 1,220 (6.4)
Otitis media diagnosis
Acute otitis media (AOM) 27,807 (76.5) 14,196 (72.8) 13,611 (80.8)
Otitis media with
effusion (OME)
8,530 (23.5) 5,294 (27.2) 3,236 (19.2)
Number of diagnoses recorded
0–1 18,924 (45.7) 8,716 (39.2) 10,208 (53.3)
2–3 20,621 (50.1) 12,278 (55.5) 8,343 (43.8)
4–5 1,683 (4.1) 1,147 (5.2) 536 (2.8)
≥6 163 (0.4) 115 (0.5) 48 (0.3)
Clinician characteristics (n = 108) (n = 53) (n = 61)
Gender
Female 78 (77.2) 36 (76.6) 46 (79.3)
Years in practice
<5 11 (10.9) 8 (17.0) 4 (6.9)
5–15 44 (43.6) 18 (38.3) 28 (48.3)
>15 46 (45.5) 21 (44.7) 26 (44.8)
Proportion of visits from patients ≤3 years in age
<0.6 50 (46.3) 23 (43.4) 29 (47.5)
≥0.6 58 (53.7) 30 (56.6) 32 (52.5)
Proportion of otitis media visits from patients with a comorbidity increasing the risk of OM
<0.04 76 (70.4) 37 (69.8) 44 (72.1)
≥0.04 32 (29.6) 16 (30.2) 17 (27.9)
Proportion of visits from patients with ≥3 diagnoses
<0.2 71 (65.7) 29 (54.7) 46 (75.4)
≥0.2 37 (34.3) 24 (45.3) 15 (24.6)
Burden of otitis media visits
≤2 visits per clinical day
per clinician
55 (50.9) 24 (45.3) 37 (60.7)
>2 visits per clinical day
per clinician
53 (49.1) 29 (54.7) 24 (39.3)
Patient characteristics (n = 20,656) (n = 10,645) (n = 10,036)
Gender
Female 9,962 (48.2) 5,184 (48.8) 4,765 (47.6)
continued
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Association of Feedback with CDS Adoption
Feedback reversed a declining trend in CDS use. Figure 2 graphs the fre-
quency of tool use at the visit level for each month of the study for prac-
tices randomized to feedback or none. Although the rate of adoption was
initially higher in the CDS-only group, the rate declined by 6.8 percentage
points during the 10-month feedback period compared to the 12-month
baseline. In the group that received feedback, the rate of tool use
increased by 2.2 percentage points following the introduction of clinician
feedback. The relative difference of 9.0 percentage points was statistically
significant (p = .001).
We also focused on tool use at the clinician-month level, because the
decision to use or not use the tool was made by each individual clinician,
and the impact of feedback on CDS use was even more pronounced. At
the clinician-month level, the rate of tool use declined by 18.9 percentage
points in the CDS-only group over time, and increased by 7.8 percentage
points in the group receiving feedback, a relative difference of 26.7 per-
centage points (p = .004). Results were consistent in secondary analyses
limited to clinician-months with 10 or more eligible visits. Results were
also unchanged in sensitivity analyses in which the outcome was clinician
use of the CDS at greater than 5 percent or 10 percent of visits in a given
month as opposed to any tool use.
Next, we examined the association of feedback with CDS use among
those with low versus high OM guideline adherence prior to the implementa-









(n = 41,391), % (n = 22,256), % (n = 19,135), %
Age
0–6 months 1,381 (6.7) 734 (6.9) 645 (6.4)
>6–≤24 months 6,607 (32.0) 3,325 (31.3) 3,269 (32.7)
>2–≤5 years 6,343 (30.7) 3,199 (30.1) 3,137 (31.3)
>5 years 6,325 (30.6) 3,362 (31.7) 2,960 (29.6)
Comorbidity that increases the risk of otitis media
Present 663 (3.2) 347 (3.3) 316 (3.2)
Not present 19,993 (96.8) 10,273 (96.7) 9,695 (96.8)
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found that feedback resulted in a greater increase in CDS use among those
with low versus high adherence to guidelines for antibiotic prescribing (15.0
percent vs. 4.1 percent increase for first-line amoxicillin and a 12.5 percent
increase vs. a 2.0 percent decline in CDS use for high-dose amoxicillin). This
difference was not observed for metrics related to pain assessment and
management.
















Baseline Period      Feedback Period     
Figure 2: Comparison of CDS Use before and after Clinician Performance
Feedback
Note. The difference in difference estimate on the frequency of any tool use at the practice level is
9.0 percent with a p-value < .001 based on two-sample t-test. In the Baseline Period, all practices
had access to CDS only. In the Feedback Period the CDS+Feedback Practices had access to both
interventions.
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Association of CDS Use with OM Guideline Adherence
In multivariable models, we found that CDS use was associated with
improved guideline adherence (Table 2). For the comprehensive measures of
perfect AOM and OME care, tool use was associated with relative increases
of 7.5 (p < .001) and 8.6 (p = .01) percentage points, respectively. For any
OM, there was a 48.2 percentage point relative increase in treatment of pain.
For AOM, there was a 5.4 percentage point relative increase in use of amoxi-
cillin as a first-line therapy and a 4.9 percentage point increase in the prescrib-
ing of an appropriate antibiotic for penicillin-allergic patients. In addition,
there was a 17.0 percentage point relative increase in prescribing of high-dose
amoxicillin. However, tool use was associated with a slight increase (2.7 per-
cent) in the prescription of antibiotics when they were not indicated. For
OME, guideline adherence also improved. We found a 12.0 percentage point
relative increase in adequate diagnostic evaluation.
We next examined the impact of tool use on guideline adherence sepa-
rately among clinicians with different levels of performance prior to the study
start (Table 3). While CDS use improved guideline adherence in all groups,
the group with high baseline guideline adherence had the fewest metrics that
improved significantly. The magnitude of improvement was greatest in the
group with low guideline adherence prior to the study start.
Context of Decision to Use OM CDS
To contextualize the results of this study, we sought feedback from clinicians
at study sites. Their responses fit into Rogers’ Theory of Diffusion of Innova-
tions. These perceptions are presented to contextualize the study results. In
terms of the relative advantage of the system, providers perceived several bene-
fits of the OMCDS relative to usual EHR use. These included the visual time-
line of past OM episodes, the automatic calculation of drug doses, and photos
of OM that could be shown to parents. However, clinicians also raised con-
cerns regarding the number of “clicks” needed to use the system, which was
perceived as inefficient. For compatibility, clinician enthusiasm for the tool was
decreased because of the change in workflow that was required, especially for
visits with multiple problems. Clinicians were accustomed to existing features
in the EHR. They felt that they already knew the OM guidelines or preferred
to use their own clinical judgment. In terms of complexity, those reluctant to use
the OM decision support perceived that entering information into the history
and physical section of the CDS was complex compared to entering data into
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free text progress notes. Clinicians also perceived that the tool worked best
with clear-cut symptoms. Although the system could be tried on a limited
basis and the feedback intervention summarized results so they could be more
readily appreciated, clinicians did not provide comments related to the
domains of trialability, being able to experiment with the system on a limited
Table 2: Association of Clinical Decision Support Use with Otitis Media
Guideline Adherence
Guideline Adherence Metric*
(n = Number of Visits)




Use –No CDS Use)
(p-value)†6,752 visits (%) 34,639 visits (%)
Comprehensivemeasures‡
Comprehensive AOM care
Achieved (n = 2,888) 851 (20.0) 2,037 (10.9) 7.5 (<.001)
Not achieved (n = 19,983) 3,400 (80.0) 16,583 (89.1)
ComprehensiveOME care
Achieved (n = 180) 54 (14.0) 126 (3.7) 8.6 (.01)
Not achieved (n = 3,611) 332 (86.0) 3,279 (96.3)
All otitis media (OM)
OM: Pain assessed
Done (n = 39,868) 6,498 (96.2) 33,370 (96.3) 1.2 (.45)
Not done (n = 1,523) 254 (3.8) 1,269 (3.7)
OM: Pain treated
Done (n = 2,730) 983 (82.0) 1,747 (32.5) 48.2 (<.001)
Not done (n = 3,849) 216 (18.0) 3,633 (67.5)
Acute otitis media (AOM)
AOM: Adequate diagnostic evaluation
Done (n = 12,969) 2,559 (53.2) 10,410 (45.3) 7.5 (.2)
Not done (n = 14,838) 2,255 (46.8) 12,583 (54.7)
AOM: Amoxicillin used as first-line therapy
Done (n = 15,191) 3,170 (84.9) 12,021 (76.6) 5.4 (.007)
Not done (n = 4,228) 563 (15.1) 3,665 (23.4)
AOM: Appropriate antibiotic for penicillin-allergic patients
Done (n = 1,131) 223 (81.1) 908 (76.9) 4.9 (.04)
Not done (n = 324) 52 (18.9) 272 (23.1)
AOM:High-dose Amoxicillin prescribed
Done (n = 9,608) 2,484 (77.9) 7,124 (58.9) 16.8 (.02)
Not done (n = 5,678) 705 (22.1) 4,973 (41.1)
AOM: Antibiotics appropriately not prescribed
Done (n = 937) 117 (4.2) 820 (6.6) 2.7 (<.001)
Not done (n = 14,379) 2,698 (95.8) 11,681 (93.4)
continued
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basis, or observability, the ability to see a difference in outcomes based on sys-
tem use.
DISCUSSION
With the dramatic increase in EHR and CDS implementation supported by
meaningful use incentives, developing optimal strategies to accelerate innova-
tion in health care delivery through EHRs has become increasingly impor-
tant. This study combined a characterization of the adoption of an OM CDS
system, an analysis of the impact of feedback on CDS use, and an examination
of the impact of CDS use on OM guideline adherence among clinicians with
access to the CDS tool. We found low rates of overall tool use and high levels
of variability across practices and that clinician performance feedback
reversed a declining trend in CDS use. Clinicians with lower rates of guideline
adherence prior to the study start experienced greater benefits from CDS use
than others when they received feedback for these metrics. CDS use was most
effective at improving adherence to OM guidelines among clinicians with the
lowest baseline guideline adherence.
Table 2. Continued
Guideline Adherence Metric*
(n = Number of Visits)




Use –No CDS Use)
(p-value)†6,752 visits (%) 34,639 visits (%)
Otitis media with effusion (OME)
OME: Adequate diagnostic evaluation
Done (n = 613) 198 (19.1) 415 (5.5) 12.0 (.01)
Not done (n = 7,917) 836 (80.9) 7,081 (94.5)
OME: Antibiotics not prescribed
Done (n = 2,818) 263 (88.6) 2,555 (87.1) 1.4 (.6)
Not done (n = 411) 34 (11.4) 377 (12.9)
Note. These results describe the difference in achievement (yes/no) of each quality metric between
visits where the CDSwas used versus visits where the CDSwas not used. All clinicians had access
to the CDS. Bold text indicates p < .05.
*Guideline adherence metrics were defined based on national guidelines, with input from a local
advisory panel.
†A marginal model with a logit link function and robust standard error estimates accounting for
clustering in practices was used. Model included tool use (yes/no) and controlled for patient, clini-
cian, and visit-level covariates.
‡Comprehensive care refers to visits eligible for at least three individual quality metrics with all of
them achieved.
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Table 3: Association of CDS Use with Otitis Media Guideline Adherence
Metrics among Clinicians with Different Levels of Otitis Media Guideline
Adherence Prior to CDS Implementation
Guideline Adherence Metric* (n = Number of Visits)
Percentage Difference in Achievement of
Guideline Adherence Metric among Clinicians
Using Versus Not Using the OM CDS (p-value)†




Comprehensive AOM care (n = 20,860) 3.8 (.444) 7.9 (.001) 10.9 (.011)
ComprehensiveOME care (n = 3,577) 6.6 (.217) 17.8 (.180) 5.5 (.048)
All otitis media (OM)
OM: Pain assessed (n = 38,286) 0.1 (.298) 0.2 (.661) 1.0 (.646)
OM: Pain treated (n = 5,992) 13.2 (<.001) 46.1 (<.001) 70.1 (<.001)
Acute otitis media (AOM)
AOM: Adequate diagnostic
evaluation (n = 25,472)
11.8 (.330) 2.3 (.748) 30.0 (<.001)
AOM:Amoxicillin used as
first-line therapy (n = 17,721)
0.9 (.508) 6.0 (.001) 5.5 (.177)
AOM: Appropriate antibiotic for
penicillin-allergic patients (n = 1,289)
3.1 (.495) 2.9 (.400) 11.6 (.044)
AOM:High-dose Amoxicillin
prescribed (n = 14,095)
2.0 (.002) 13.0 (<.001) 13.9 (.153)
AOM: Antibiotics appropriately
not prescribed (n = 14,150)
7.5 (<.001) 2.6 (.002) 0.1 (.954)
Otitis media with effusion (OME)
OME: Adequate diagnostic
evaluation (n = 8,124)
17.8 (.007) 1.9 (.419) 8.7 (.022)
OME: Antibiotics not prescribed (n = 3,040) 1.7 (.532) 5.9 (.034) 1.6 (.811)
Note. These results describe the difference in achievement (yes/no) of each guideline adherencemet-
ric between visits where the tool was used versus visits where the tool was not used, separately for cli-
nicians with low, median, or high OM guideline adherence prior to CDS implementation. Overall,
those with low guideline adherence prior to the study start benefitted most from using the CDS. For
example, CDS use was associated with a 10.9 percentage point improvement in adherence to com-
prehensive AOM care for those with low guideline adherence prior to the study compared to a 7.9
percentage point improvement among thosewithmedian guideline adherence and a drop of 3.8 per-
centage points among thosewith high guideline adherence. Bold text indicates p<.05.
*Guideline adherence metrics were defined based on national guidelines, with input from a local
advisory panel. Separately for each metric, clinician guideline adherence was defined by examin-
ing the 12 months prior to the implementation of the CDS. A single clinician could rate in the
highest group for onemetric and themedian or low group for another.
†A marginal model with a logit link function and robust standard error estimates accounted for
clustering in practices was used. Model included tool use (yes/no) and controlled for patient, clini-
cian, and visit-level covariates.
‡Comprehensive guideline adherence refers to visits eligible for at least three individual quality
metrics with all of them achieved.
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Clinicians ignored the OM tool at 80 percent of eligible visits. Two per-
cent of clinicians never used the CDS, and 11 percent used the tool during a
trial period but not again. These results underscore the importance of contin-
ued research to define how best to encourage CDS adoption. Although studies
have considered the association between workflows as well as clinician and
patient characteristics and CDS adoption (Garg et al. 2005; Kawamoto et al.
2005; Romano and Stafford 2011), this study extends that work by focusing
on the relationship between characteristics of visits, clinicians, and patients
and the outcome of tool use. Rogers’ theory of innovation suggests that rela-
tive advantage, compatibility, and complexity are important determinants of
the adoption of a new innovation and our qualitative results support the
relevance of all three to clinician decisions regarding tool use (Rogers 2003).
Specifically, we found that clinicians who infrequently diagnose OM, those
likely to benefit most from the tool, were 11 percentage points more likely to
use the CDS than others. In addition, the tool was more likely to be used at
visits with less medical complexity. These visits, particularly those with one
diagnosis, fit more readily into the workflow supported by the OM CDS. Still,
the low rates of adoption in this study underscore the potential benefit of
usability testing and focused design work to broaden the range of visits at
which clinician and practice workflows are compatible with CDS use (Nielsen
1993). The low rates of adoption also suggest that CDS may be optimally
combined with quality improvement initiatives that alter physician workflow
to achieve a desired aim, such as, in this case, improvements in OM care.
Feedback reversed a declining trend in tool use. Our results are consis-
tent with an observational study that found an association between clinician
self-reported receipt of feedback in adult primary care and response to clinical
reminders (Mayo-Smith and Agrawal 2007). Larger studies focused on the
outcome of actual CDS use have not addressed this question. According to
Rogers’ Theory, observability, the ability to see a difference in outcomes
based on system use, drives adoption. In this study, feedback communicated
the results of CDS use to clinicians, increasing observability (Rogers 2003). In
addition, feedback provided achievable benchmarks by highlighting the
results for “top performers,” an evidence-based approach for improving prac-
tice with feedback (Kiefe et al. 1998;Weissman et al. 1999). Finally, each clini-
cian was presented with a comparison of his or her own results with those of
the practice and network. Prior research suggests that this approach, known as
“peer comparison feedback,” may be more effective than feedback without
these comparisons (Buntinx et al. 1993; Hadjianastassiou, Karadaglis, and
Gavalas 2001).
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Even though feedback proved effective in reversing the decline in
OM use, the CDS was still used at less than 25 percent of eligible vis-
its. In addition to characteristics of the innovation (CDS) emphasized by
Rogers, a growing literature suggests the importance of provider, organi-
zational, and structural factors to implementation outcomes including
adoption (Chaudoir, Dugan, and Barr 2013). In the case of the OM
CDS, the absence of reimbursement tied to OM guideline adherence, a
structural factor, and a lack of emphasis on accountability for adherence
to OM guidelines among practice leaders, an organizational factor,
might have limited adoption. In addition, despite education regarding
tool use and a review of evidence behind the guidelines in educational
sessions delivered in-person to clinicians, some clinicians might have
remained uncomfortable with tool use or distrusted national guidelines.
Tool use was not associated with 100 percent guideline adherence; even
when the tool was used, clinicians rejected some guidelines. While our
results support the implementation of feedback to foster CDS adoption,
situating the intervention within a quality improvement framework that
more actively engaged organizational leadership and practitioners might
have better improved adoption (Kaplan et al. 2010).
We previously found that the implementation of CDS or feedback
for OM resulted in modest improvements in guideline adherence for
practices randomized to these interventions (Forrest et al. 2013). This
study demonstrates the additional benefit to guideline adherence that
could potentially be achieved with higher rates of CDS adoption. Over-
all, benefits of CDS use were far greater than the median improvement
of 4 percent reported in systematic reviews (Shojania et al. 2009) or the
less than 5 percentage point improvement in comprehensive AOM or
OME care observed between CDS versus non-CDS practices in our
trial (Forrest et al. 2013). We also found that the magnitude and scope
of improvement in guideline adherence with CDS use was greatest for
clinicians with low baseline adherence. Although all groups benefitted,
our results highlight the importance of fostering the adoption of CDS
tools among underperforming clinicians.
This study had several limitations. First, the study is not an evalua-
tion of the clinical trial as randomized but a description of CDS adoption
among the study arm randomized to receive the CDS tool. In addition,
the study was conducted within one health system in one region of the
United States. Nonetheless, the substantial heterogeneity in tool use across
sites highlights the importance of clinician and practice characteristics to
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CDS adoption. Although this study focused on a single clinical condition,
OM is among the most common pediatric conditions, which provided an
ideal model to study CDS adoption as a strategy to improve both diagno-
sis and management. Because all clinicians had access to the “history
panel,” the independent effect of this summary of prior OM care could
not be evaluated. As a clinician’s workflow for any given visit in this study
was determined by the appearance of the history panel and an unrecorded
conversation with the family in the exam room, rather than relying on the
chief complaint, we did not analyze the independent impact of the chief
complaint on CDS use. We instead used the number of diagnoses as a
measure of visit complexity. Furthermore, it was beyond the scope of this
study to evaluate the duration or intensity of feedback likely to yield the
greatest benefit. Nevertheless, we found that our standardized bimonthly
reports were effective at fostering CDS use. Finally, comments provided
by clinicians at the time of feedback summarized perceptions of the tool.
In the absence of formal usability testing, which was beyond the scope of
this study, we could not determine whether actual tool use matched
perceptions.
CONCLUSIONS
We found low rates of tool use and high variability in the adoption of an inno-
vative OM CDS tool that provided actionable information to clinicians in real
time. Implementing performance feedback along with clinical decision sup-
port was an effective strategy to promote adoption. These results support the
use of feedback in tandem with CDS as a means of fostering guideline-based
care. However, additional strategies and incentives are needed to fully realize
the benefits of CDS for guideline adherence.
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Figure S1: Components of the Otitis Media Clinical Decision Support
System.
Figure S2: Physician Performance Feedback. (After an initial 8-month
period of clinical decision support use alone, clinicians randomized to the
feedback group received six rounds of hand-delivered feedback over a 10-
month period. Quality metrics were based on American Academy of Pediat-
rics guidelines for acute Otitis Media. Data were presented on the top 10% of
performers throughout the entire care network.)
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